Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy . . . In this study, we aimed to evaluate the GFR via serum cystatin C for the early detection of DN among DM patients We conducted the meta-analysis to systematically analyze the relevant studies for determining the predictive value of serum cystatin C for the early detection of DN
Diagnostic value of serum cystatin C for diabetic nephropathy: a meta . . . Although dozens of studies have investigated the relationship between the content of serum cystatin C (Cys-C) and diabetic nephropathy (DN), the results are still controversial Hence, This study aims to explore the accuracy of serum Cys-C for diagnosing DN by meta-analysis
Diagnostic value of serum cystatin C for diabetic nephropathy: a meta . . . Although dozens of studies have investigated the relationship between the content of serum cystatin C (Cys-C) and diabetic nephropathy (DN), the results are still controversial Hence, This study aims to explore the accuracy of serum Cys-C for diagnosing DN by meta-analysis
Clinical Utility of Serum Cystatin C in Predicting Diabetic Nephropathy . . . Key Words Diabetic nephropathy • Serum cystatin C • Glomerular filtration rate • Meta-analysis f predictors for diabetic nephropathy (DN) in diabetes mellitus (DM) without microalbuminuria, macroalbuminuria or retinopathy Methods: PubM
Serum cystatin C as an early marker of nephropathy among type 2 . . . Aim: The varying views as to the usefulness of serum cystatin C (CysC) as an early marker of diabetic nephropathy (DN) prompted us to investigate existing literature to determine whether serum CysC can be used as an early marker of DN using a meta-analysis approach